IDENTIFICATION OF A CLEAVAGE SITE DIRECTING THE IMMUNOCHEMICAL DETECTION OF MOLECULAR ABNORMALITIES IN TYPE-IIA VONWILLEBRAND-FACTOR

被引:313
作者
DENT, JA
BERKOWITZ, SD
WARE, J
KASPER, CK
RUGGERI, ZM
机构
[1] SCRIPPS CLIN & RES FDN, RES INST, ROON RES CTR ARTERIOSCLEROSIS & THROMBOSIS, LA JOLLA, CA 92037 USA
[2] SCRIPPS CLIN & RES FDN, RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA
关键词
bleeding disorder; proteolytic degradation; von Willebrand disease;
D O I
10.1073/pnas.87.16.6306
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Proteolytic cleavage of the von Willebrand factor subunit may be important for processing and/or function of the molecule and is altered in certain subtypes of von Willebrand disease. It results in the generation of two main fragments with apparent molecular masses of 140 kDa and 176 kDa from the 225-kDa subunit. We have now obtained chemical evidence to locate the protease-sensitive bond between residues Tyr-842 and Met-843, a site that appears to reflect the specificity of calcium-dependent neutral proteases (calpains). Antibodies were raised against four synthetic peptides that represented sequences immediately preceding or following or including the cleavage site. One antibody (against the fragment from Ala-837 through Asp 851) reacted only with the intact subunit, and its epitope included the cleavage site. All others reacted specifically with either the 140-kDa or the 176-kDa fragment, demonstrating their origin from a single cleavage. In samples of purified von Willebrand factor from four of five patients with type IIA von Willebrand disease, the anti-peptide antibodies showed markedly decreased reactivity with either the 140-kDa or the 176-kDa fragment, suggesting the existence of distinct molecular abnormalities clustered around the cleavage site. Thus, in the majority of type IIA patients, a common pathogenetic mechanism may lead to the disappearance of the larger multimers as a consequence of structural changes that may expose a sensitive bond to the action of specific proteases. These studies demonstrate the use of anti-peptide antibodies directed at a relevant structural domain for the immunochemical differentiation of normal and mutant molecules.
引用
收藏
页码:6306 / 6310
页数:5
相关论文
共 36 条
[1]  
BATLLE J, 1986, BLOOD, V68, P1207
[2]   EPITOPE MAPPING OF THE VONWILLEBRAND-FACTOR SUBUNIT DISTINGUISHES FRAGMENTS PRESENT IN NORMAL AND TYPE-IIA VONWILLEBRAND DISEASE FROM THOSE GENERATED BY PLASMIN [J].
BERKOWITZ, SD ;
DENT, J ;
ROBERTS, J ;
FUJIMURA, Y ;
PLOW, EF ;
TITANI, K ;
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (02) :524-531
[3]  
BERKOWITZ SD, 1988, BLOOD, V72, P721
[4]  
BERLINER S, 1988, J BIOL CHEM, V263, P7500
[5]   GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[6]   FACTOR-VIII ON VASCULAR INTIMA - POSSIBLE IMPORTANCE IN HEMOSTASIS AND THROMBOSIS [J].
BLOOM, AL ;
GIDDINGS, JC ;
WILKS, CJ .
NATURE-NEW BIOLOGY, 1973, 241 (111) :217-219
[7]  
BOCKENSTEDT P, 1988, BLOOD S, V1, pA291
[8]   NUCLEOTIDE-SEQUENCE OF PRE-PRO-VONWILLEBRAND FACTOR CDNA [J].
BONTHRON, D ;
ORR, EC ;
MITSOCK, LM ;
GINSBURG, D ;
HANDIN, RI ;
ORKIN, SH .
NUCLEIC ACIDS RESEARCH, 1986, 14 (17) :7125-7127
[9]  
BUDDE U, 1986, BLOOD, V68, P1213
[10]  
CHANG HY, 1989, BLOOD S, V1, pA131